Ovarian Cancer
Results from Chemo-Immunotherapy in Murine Model are Dismal
Published in Women's Health Weekly, October 12th, 2000
"As a majority of ovarian cancer patients will ultimately develop recurrent disease, there is an urgent need for alternative or additional approaches in the treatment of this cancer," wrote A.H. Klimp and colleagues, University of Groningen. "The antitumor effect of intraperitoneally (i.p.) administered cisplatin, liposomal muramyltripeptide phosphatidylethanolamine (L-MTP-PE), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were investigated using an intraperitoneally growing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Cell Samples from Needle Aspirates Mark Disease Risk - Osteoporosis
Study Findings Refute Beneficial Effects of Statin Medications - Uterine Anomalies
Pelvic Ultrasound Reveals Higher Prevalence than Previously Thought - Breast Cancer
Depressed Women at Greater Risk - Breast Cancer
Estradiol Level May Indicate Who Benefits Most from Raloxifene Treatment - Breast Cancer
Radiotherapy Booster Cuts Risk of Recurrence - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
